Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine + Etoposide + Cyclophosphamide in Pediatric Relapsed/Refractory Leukemia
NCT00315705Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Sanofi. Started Mar 2006; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00315705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315705.